Management indicated the pivotal and ASPIRE trials are "on track to complete dosing in the second quarter of 2026." The company expects to initiate BLA-enabling process performance qualification (PPQ) ...

ZHEJIANG, ZHEJIANG, CHINA, March 24, 2026 /EINPresswire.com/ -- In an era defined by rapid urbanization and the global ...

Joining me on today’s call are Sean Nolan, Taysha Gene Therapies, Inc.'s Chief Executive Officer; Sukumar Nagendran, ...

Gesture control robotics replaces traditional buttons and joysticks with natural hand movements. This approach improves user ...

Cato Networks, the SASE leader, today unveiled two major innovations for the Cato SASE Platform to secure enterprise AI adoption a ...

Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2025 Earnings Call Transcript March 19, 2026 Taysha Gene Therapies, Inc. beats earnings expectations. Reported EPS is $-0.08711, expectations were ...

A team of Korean researchers has developed the world's first technology that can freely connect and disconnect core computing ...

The AKD1500 is a neuromorphic Edge AI accelerator co-processor chip designed to deliver performance with minimal power ...

President Donald Trump says his administration is considering “winding down” military operations in the Middle East even as ...

On the authorization side, A3F was selected under DOE's Advanced Nuclear Fuel Line Pilot Program, which is intended to ...

Karpathy's autoresearch and the cognitive labor displacement thesis converge on the same conclusion: the scientific method is ...

The great thing about mock draft season is seeing the different opinions out there as to who the Dallas Cowboys, and the rest ...